Physician profile
Joel L Koslow
NPI 1063479186
$1,870.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $194 · 2021: $568 · 2022: $748 · 2023: $33.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $464.67 | 2019-2022 | |
| Novo Nordisk INC | $236.71 | 2021-2022 | |
| Pfizer INC. | $219.01 | 2019-2022 | |
| Lilly USA, LLC | $135.64 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $123.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.61 | 2019-2022 | |
| Allergan, INC. | $73.22 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $67.57 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $53.92 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $43.47 | 2021 | |
| Glaxosmithkline, LLC. | $42.53 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.46 | 2019-2021 | |
| Astellas Pharma US INC | $35.74 | 2021-2022 | |
| Horizon Therapeutics Plc | $34.34 | 2019-2021 | |
| Esperion Therapeutics, INC. | $32.64 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.50 | 2019-2023 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $25.21 | 2022 | |
| Boston Scientific Corporation | $24.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.78 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.53 | 2022 | |
| Abbott Laboratories | $18.07 | 2022 | |
| Mylan Specialty L.P. | $17.90 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.40 | 2021 | |
| Eisai INC. | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Koslow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.